Lopinavir/Ritonavir Monotherapy as Second-line Antiretroviral Treatment in Resource-Limited Settings: Week 104 Analysis of AIDS Clinical Trials Group (ACTG) A5230
Pharmacology, Toxicology and Pharmaceutical Science
2
3%
Agricultural and Biological Sciences
2
3%
Immunology and Microbiology
2
3%
Other
6
10%
Unknown
14
24%
Attention Score in Context
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 April 2015.
All research outputs
#14,803,937
of 22,792,160 outputs
Outputs from Clinical Infectious Diseases
#12,484
of 15,783 outputs
Outputs of similar age
#142,569
of 255,035 outputs
Outputs of similar age from Clinical Infectious Diseases
#122
of 196 outputs
Altmetric has tracked 22,792,160 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 15,783 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.4. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 255,035 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 41st percentile – i.e., 41% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 196 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.
